CSS
ERNA icon

Cubist Systematic Strategies’s Eterna Therapeutics ERNA Stock Holding History

Cubist Systematic Strategies’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-57
Closed -$6.28K – 3031
2024
Q4 		$6.28K Buy
+57
New +$15.5K ﹤0.01% 2873
2022
Q4 		– Sell
-3
Closed -$6K – 4334
2022
Q3 		$6K Sell
3
-1
-25% -$3.45K ﹤0.01% 4308
2022
Q2 		$14K Sell
4
-2
-33% -$14.4K ﹤0.01% 4245
2022
Q1 		$85K Hold
6
– – ﹤0.01% 3281
2021
Q4 		$194K Buy
+6
New +$326K ﹤0.01% 3041

Other funds holding ERNA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CPWM
Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return
SCA
Sippican Capital Advisors Boston, Massachusetts $164M AUM 35.17% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Cubist Systematic Strategies's ERNA Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Eterna Therapeutics (ERNA) in Q1 2025, closing a stake of 57 shares — an estimated $6.28K sold.

Cubist Systematic Strategies first reported a position in ERNA in Q4 2021 and held it in 5 quarters. The position peaked at $194K in Q4 2021. 20 funds tracked by Wall St. Rank hold ERNA as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Eterna Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 57 Eterna Therapeutics shares in Q1 2025, an estimated $6.28K.
  • Cubist Systematic Strategies first reported a position in Eterna Therapeutics in Q4 2021 and held it in 5 quarters.
  • Cubist Systematic Strategies's Eterna Therapeutics position peaked at $194K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.